ARTIFICIAL CELL TECHNOLOGIES, INC.

Company Information

Company Name
ARTIFICIAL CELL TECHNOLOGIES, INC.
Address
5 Science Park, 3rd Floor
NEW HAVEN, CT, 06511-1989
Phone
n/a
URL
http://www.artificialcelltech.com
DUNS
361522811
Number of Employees
9
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,642,505.00
4
SBIR Phase II
$2,702,977.00
1
Chart code to be here

Award List

  1. Synthetic nanocapsule malaria vaccines

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The goal of this project is to produce novel synthetic malaria vaccines based on epitopes of the circumsporozoite (CS) protein of Plasmodium falciparum, the causa ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Polypeptide Multilayer Nanofilms for Synthetic Biomatrix Development

    Amount: $331,582.00

    DESCRIPTION (provided by applicant): This SBIR Phase I project will determine the feasibility of applying polypeptide multilayer nanofilm technology to synthetic biomatrix development and commercializ ...

    SBIR Phase I 2009 Department of Health and Human Services
  3. Synthetic nanoparticle vaccines for RSV

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Respiratory syncytial virus (RSV) is the most important cause of severe lower respiratory tract illness in infants and the elderly. There is no approved vaccine de ...

    SBIR Phase I 2011 Department of Health and Human Services
  4. Formulation of LbL microparticle vaccine in microneedle array for intradermal del

    Amount: $110,923.00

    Abstract The ability of the immune system to recognize and initiate an immune response to foreign particles such as bacteria and viruses has generated interest in development of particulate vaccine te ...

    SBIR Phase I 2014 Department of Health and Human Services
  5. Synthetic microparticle malaria vaccine

    Amount: $2,702,977.00

    Abstract This Phase II project will develop a novel synthetic microparticle vaccine for malaria, using the T1BT* epitopes of the circumsporozoite (CS) protein of Plasmodium falciparum, the causative a ...

    SBIR Phase II 2014 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government